Vanda Pharmaceuticals Inc (NASDAQ:VNDA)

12.25
Data as of Dec 19
 -0.48 / -3.77%
Today’s Change
8.34
Today|||52-Week Range
19.25
-1.29%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Biotechnology
MARKET CAP
$485.7M

Company Description

Vanda Pharmaceuticals Inc. is a biopharmaceutical company focused on the development and commercialization of products for the treatment of central nervous system disorders. Its product portfolio includes Fanapt and Tasimelteon. The Fanapt product is a compound for the treatment of schizophrenia, the oral formulation of, which is currently being marketed and sold in the U.S. by Novartis. The Tasimelteon product is a compound for the treatment of sleep and mood disorders, including circadian rhythm sleep disorders, which is currently in clinical development. Vanda Pharmaceuticals was founded by Mihael Hristos Polymeropoulos and Argeris N. Karabelas in 2002 and is headquartered in Washington, DC.

Contact Information

Vanda Pharmaceuticals, Inc.
2200 Pennsylvania Avenue NW
Washington District Of Columbia 20037
P:(202) 734-3400
Investor Relations:

Employees

Shareholders

Other institutional64.51%
Mutual fund holders42.85%
Individual stakeholders31.22%

Top Executives

Mihael Hristos PolymeropoulosPresident, Chief Executive Officer & Director
James Patrick KellyCFO, Secretary, Treasurer & Senior Vice President
Paolo BaroldiChief Medical Officer & Senior Vice President
Gunther BirznieksVice President-Business Development
Deepak Shripad PhadkeVice President-Manufacturing

To view my watchlist

Not a member yet?

Sign up now for a free account

Most stock quote data provided by BATS. Market indices are shown in real time, except for the DJIA, which is delayed by two minutes. All times are ET. Disclaimer.

Morningstar: © 2014 Morningstar, Inc. All Rights Reserved.

Factset: FactSet Research Systems Inc. 2014. All rights reserved.

Chicago Mercantile Association: Certain market data is the property of Chicago Mercantile Exchange Inc. and its licensors. All rights reserved.

Dow Jones: The Dow Jones branded indices are proprietary to and are calculated, distributed and marketed by DJI Opco, a subsidiary of S&P Dow Jones Indices LLC and have been licensed for use to S&P Opco, LLC and CNN. Standard & Poor's and S&P are registered trademarks of Standard & Poor’s Financial Services LLC and Dow Jones is a registered trademark of Dow Jones Trademark Holdings LLC. All content of the Dow Jones branded indices © S&P Dow Jones Indices LLC 2014 and/or its affiliates.